Trial: 202104143

Phase II Study of a Personalized Neoantigen Vaccine in Combination with Durvalumab (MEDI4736) in Extensive Stage Small Cell Lung Cancer

Phase

II

Principal Investigator

Ward, Jeffrey

Disease Site

Lung

Learn more about this study at: clinicaltrials.gov